DMF was also identified to induce apoptosis of hematopoietic cancer cells by inactivating NF-κB and down-regulating Bcl-XL and XIAP expression (Tsubaki et al., 2014). This evidence concerns the gene BCL2L1 and hematopoietic and lymphoid cell neoplasm.